Concepedia

Skeletal effects of exemestane on bone-mineral density, bone biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES): a randomised controlled study

Robert E. Coleman, Linda M. Banks, Samia I. Girgis, Lucy Kilburn, Eduard Vrdoljak, John Fox, Simon Cawthorn, Ashraf Patel, Claire Snowdon, Emma Hall,

The Lancet Oncology · 2007 · 427 citations · 20 references

DOI

Concepts

References

20

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer

Anthony Howell, Jack Cuzick, M Baum et al. · The Lancet · 2005 · 2.3K citations

, , +6

A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer

R. Charles Coombes, Emma Hall, Lorna J. Gibson et al. · New England Journal of Medicine · 2004 · 1.8K citations · Full text

, , +13

A Comparison of Letrozole and Tamoxifen in Postmenopausal Women with Early Breast Cancer

New England Journal of Medicine · 2005 · 1.6K citations · Full text

, , +9

Tamoxifen for the Prevention of Breast Cancer: Current Status of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

Bernard Fisher, Joseph P. Costantino, D. Lawrence Wickerham et al. · JNCI Journal of the National Cancer Institute · 2005 · 1.3K citations

, , +15

Effects of Tamoxifen on Bone Mineral Density in Postmenopausal Women with Breast Cancer

Richard R. Love, Richard B. Mazess, Howard S. Barden et al. · New England Journal of Medicine · 1992 · 1.1K citations · Full text

, , +17